Fieldpoint Private Securities’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$6K Sell
55
-156
-74% -$17.9K ﹤0.01% 872
2022
Q1
$27K Sell
211
-53
-20% -$7.64K 0.01% 762
2021
Q4
$48K Buy
264
+70
+36% +$12.1K 0.01% 632
2021
Q3
$29K Hold
194
0.01% 715
2021
Q2
$30K Sell
194
-292
-60% -$40.7K 0.01% 690
2021
Q1
$63K Buy
486
+346
+247% +$44.4K 0.01% 517
2020
Q4
$17K Buy
+140
New +$13.7K ﹤0.01% 741

Other funds holding OMCL

Fieldpoint Private Securities's OMCL Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Omnicell (OMCL) stake by 74% in Q2 2022, selling an estimated $17.9K and leaving 55 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #872.

Fieldpoint Private Securities first reported a position in OMCL in Q4 2020 and has held it in 7 quarters since. The position peaked at $63K in Q1 2021. 385 funds tracked by Wall St. Rank hold OMCL as of Q2 2022.

  • Fieldpoint Private Securities held 55 shares of Omnicell worth $6K as of Q2 2022.
  • Fieldpoint Private Securities sold 156 Omnicell shares in Q2 2022, an estimated $17.9K.
  • Omnicell made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #872 holding.
  • Fieldpoint Private Securities first reported a position in Omnicell in Q4 2020 and has held it in 7 quarters since.
  • Fieldpoint Private Securities's Omnicell position peaked at $63K in Q1 2021.
  • 385 funds tracked by Wall St. Rank held Omnicell as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.